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Optical characterization of ultrathin ﬁlms and interfaces
using surface plasmon polariton or surface plasmon reso-
nance SPR excitation in “free-electron-like” metals of gold
and silver was pioneered by two research groups from
Germany in the late 1960s.1,2 They showed that the SPR
phenomenon could be excited optically by the method of
attenuated total reﬂection ATR either via a very thin air
gap-“the Otto conﬁguration”-or by a route where the thin
metal ﬁlm was deposited directly on the base of a glass
prism-“the Kretschmann conﬁguration.” Both methods were
extensively used to study fundamental optical properties of
thin metal ﬁlms and inorganic/organic coatings deposited on
top of the metal ﬁlm surface. In the following years the SPR-
ATR approach became very popular for studies of monomo-
lecular assemblies of Langmuir–Blodgett ﬁlms on metals3
and later for the determination of molecular orientation4 in
such assemblies as well as for measurement of refractive
index changes occurring during phase transitions in liquid
crystals.5 Many innovative approaches describing the use of
SPR-ATR for studies of smooth, roughened, and layered ar-
chitectures have been summarized in reviews by Boardman6
and Raether.7
The Kretschmann conﬁguration has prevailed as the most
attractive mode of operation primarily because of its advan-
tages for applications in complex, opaque, and highly scat-
tering ﬂuids. This opened for real time monitoring of biomo-
lecular recognition events at surfaces, an application of SPR
that was demonstrated for the ﬁrst time in the early 1980s by
Liedberg et al.8 The work attracted considerable interest in
academia as well as in industry, and in 1990 Pharmacia
Biosensor AB today GE Healthcare-Bioscience launched
the ﬁrst instrument in a series BIACORE 1000 for biospe-
ciﬁc interaction analysis.9 The bioanalytical and biosensor
applications of SPR have dominated the open literature since
then although the technology has been employed in many
other areas as well, e.g., for studies of biomaterials, protein
adsorption phenomena, and electrochemical reactions at
electrodes. A series of excellent reviews and books on SPR
for bio- and chemical sensings has been published over the
years.10,11
In 1987 and 1988 Yeatman and Ash12 and Rothenhäusler
and Knoll13 published the ﬁrst papers on SPR microscopy or
imaging surface plasmon resonance iSPR for the examina-
tion of patterned surface architectures with a spatial reso-
lution on the micrometer length scale.14,15 The research and
development of iSPR setups have gained considerable mo-
mentum during the past ten years, in part to meet the increas-
ing demands put forward by the proteomics and high
throughput screening communities. Even though the technol-
ogy is available, still many challenges remain to be solved
before being able to apply iSPR for large scale label-free
protein analysis. For example, the nonspeciﬁc effects due to
the stickiness of proteins to surfaces and the limited shelf life
of protein biochips are examples of very challenging prob-
lems that need to be carefully addressed and solved. Never-
theless, several examples of relatively small 100 spots
and highly specialized microarrays have been successfully
developed and employed.16–18
SPR also has been successfully combined with other sur-
face analytical techniques for multiparameter characteriza-
tion of surfaces and sensing. Gordon II and Ernst used a
combination of SPR and electrochemistry to study electrode
reactions19 and Zhang et al. reported on the progress in this
particular ﬁeld in a recent survey.20 In 1991 Attridge et al.
introduced surface plasmon ﬂuorescence spectroscopy
SPFS for simultaneous label-free monitoring of binding
events and enhanced emission of capture ﬂuorophores.21 In
one of the invited contributions of the current Focus Issue of
Biointerphases, Dostálek et al. reviewed the progress in the
ﬁeld of SPFS, and they showed that subfemtomolar concen-
trations of the target molecules can be detected by taking
advantage of the electromagnetic ﬁeld enhancement and
resonant excitation in combination with efﬁcient collection
optics.
Evanescent ATR excitation of surface plasmons in planar
geometries is today a well established technology. More re-
cently, however, the research focus on SPR has been directed
toward studies of so-called localized surface plasmon reso-
nance LSPR.22 Both SPR and LSPR are associated with
excitation of collective oscillations at the surface of a metal,
but LSPR occurs in objects that are much smaller than the
wavelength of the radiation used, for example, in nanopar-
ticles, nanoholes, or periodic/aperiodic patterns thereof. The
current issue of Biointerphases presents two minireviews
that compare the sensitivity and ﬁgure of merit of LSPR in
nanoparticles and nanoholes with traditional SPR. In a third
contribution gold nanoparticles are used as a strategy to pre-
pare diffractive grating for DNA detection.
The present volume of Biointerphases contains four con-
tributions related to SPR, SPFS, LSPR, and diffractive SPR,
and they highlight recent developments and applications of
SPR in diverse ﬁelds of biosensing and biologically inspired
nanoscience and technology. Two more contribution will ap-
pear in the next volume and they are related to “ubiquitous
afﬁnity biosensing” where SPR is performed with consumer
electronic devices as computer screens and web cameras, and
“bio-organism sensing via surface enhanced Raman spectros-
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copy on controlled metal/polymer nanostructured sub-
strates.”
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Over the past two decades, label-free interaction analysis
has developed into a widely accepted tool for a range of
different applications within life science research and drug
discovery. The main driver in this revolution has been the
Swedish company Biacore AB part of GE Healthcare since
2006. In 1990 it commercialized an analytical biosensor in-
strument system based on surface plasmon resonance SPR
detection, thereby opening up a completely new way to
monitor and quantify interactions between proteins and other
biomolecules. In particular, this real-time detection method
enabled high-quality afﬁnity and kinetics data to be conve-
niently obtained, opening up a new era for the detailed char-
acterization of biomolecule binding properties.
SPR-based analysis is now widely accepted, as demon-
strated by the thousands of Biacore™ instruments sold and
the ever-increasing stream of peer reviewed articles based on
their use. For example, in 2008, the number of published
articles quoting the use of Biacore systems is expected to
reach over 10 000.
The selection of the optical phenomenon SPR as the de-
tection principle in Biacore instruments for biomolecular in-
teraction studies was based on its high sensitivity relative to
other label-free detection principles. The ability to combine
the detection method with advanced microﬂuidics handling
and a range of surface chemistries for different applications
into a fully integrated system was also a major advantage.
SPR can be conveniently miniaturized to provide multiple
detection areas on one sensor chip, which improves the
analysis throughput and referencing capabilities. Indeed, the
ﬁrst Biacore instrument had four detection areas on each sen-
sor chip and these were individually addressable via the mi-
croﬂuidics system. Later systems have increased these num-
bers e.g., 20 detection areas in Biacore A100 or 400 in
Biacore Flexchip, facilitating their use in different types of
screening applications. The gold-coated sensor surfaces are
also ideal for developing a variety of chemistries to enable
the attachment of different types of biomolecules and for
minimizing nonspeciﬁc binding.
The technology and applications for SPR-based label-free
analysis have developed tremendously since the ﬁrst Biacore
instrument was launched. For example, direct analysis of the
binding of small-molecule drug candidates to their immobi-
lized protein targets are now standard applications for sys-
tems such as Biacore T100. As evidenced by this special
edition of Biointerphases, the research focus on SPR contin-
ues with high intensity and helps drive the development of
new instruments and applications. GE Healthcare is dedi-
cated to continue this lead in the future.
